Quantcast

Latest Acthar Stories

2014-08-14 16:27:16

- Creates a diversified, high-growth therapeutic portfolio, capable of delivering substantial, sustainable value for shareholders DUBLIN, Aug.

2014-08-05 23:02:01

A recent regulatory filing exposes that adverse events occurred in 14% of patients taking Acthar in 2013.

2014-07-24 08:34:45

Net Sales $279 Million; Increase of 42% over Prior Year Non-GAAP Results ANAHEIM, Calif., July 24, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.

2014-07-11 23:01:56

A recent regulatory filing exposes that the number of adverse events in 2013 reported by patients taking Acthar was almost 14% of prescriptions.

2014-05-14 08:32:08

- Expands pipeline and broadens platform with next-generation melanocortin peptides - ANAHEIM, Calif., May 14, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.

2014-05-05 08:30:03

- Significant clinical response to Acthar was observed in patients experiencing active disease while on conventional SLE maintenance therapies - ANAHEIM, Calif., May 5, 2014 /PRNewswire/ --

2014-04-28 16:31:16

- Net Sales $227 Million; Increase 68% Year-over-Year - ANAHEIM, Calif., April 28, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.

2014-04-21 08:26:07

- Clinical results appear to correlate with reduction in anti-PLA2R antibodies ANAHEIM, Calif., April 21, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.

2014-04-07 08:29:44

--Questcor Shareholders Receive $30.00 in Cash and 0.897 Mallinckrodt Shares for Each Share of Questcor Common Stock They Own-- DUBLIN and ANAHEIM, Calif., April 7, 2014 /PRNewswire/ --

2014-02-25 16:29:30

- Fourth Quarter Net Sales $243 Million; Increase 51% Year-over-Year - ANAHEIM, Calif., Feb. 25, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.


Word of the Day
shavie
  • A trick or prank.
The word 'shavie' is related to 'shave'.